BioXcel Therapeutics, Inc. Profile Avatar - Palmy Investing

BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing …

Biotechnology
US, New Haven [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of BTAI's Analysis
CIK: 1720893 CUSIP: 09075P105 ISIN: US09075P1057 LEI: - UEI: -
Secondary Listings
BTAI has no secondary listings inside our databases.